Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek J Leishman

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Journal of Pharmacological and Toxicological Methods|November 16, 2019
Improving prediction of torsadogenic risk in the CiPA in silico model by appropriately accounting for clinical exposureDerek J Leishman
Journal of Clinical Pharmacology|July 17, 2023
The New S7B/E14 Q&A Document Provides Additional Opportunities to Replace the Thorough QT StudyBorje Darpo, Derek J Leishman
Journal of Pharmacological and Toxicological Methods|August 1, 2020
A Bayesian approach to toxicological testingJames C Felli, Derek J Leishman
Journal of Pharmacological and Toxicological Methods|June 28, 2019
Real estate diagrams: A tool to quickly assess the utility of a new predictive technologyJames C Felli, Derek J Leishman
Clinical Pharmacology and Therapeutics|February 22, 2024
The Efficacy, Effectiveness, and Efficiency of Integrated QTc Assessment: Rationalizing Approaches to New Drug ModalitiesMatthew M Abernathy, Derek J Leishman
Clinical Pharmacology and Therapeutics|April 10, 2026
Does Changing the Context of Use Change the Value Proposition of CiPA?Charles T Benson, Derek J Leishman
Clinical and Translational Science|October 15, 2024
A "one-step" approach to heart rate correction and statistical analysis applied to conscious dog QTc studiesDerek D Best, Matthew M Abernathy, Derek J Leishman
Journal of Pharmacological and Toxicological Methods|April 25, 2025
The statistical and pharmacological sensitivity of nonclinical QTc analysis comparing jacketed telemetry and multilead snapshot recording in the same dogsMatthew M Abernathy, Derek D Best, Derek J Leishman
Journal of Pharmacological and Toxicological Methods|August 10, 2020
Revisiting the hERG safety margin after 20 years of routine hERG screeningDerek J Leishman, Matthew M Abernathy, Evan B Wang
Regulatory Toxicology and Pharmacology : RTP|March 31, 2025
Prevalence and sample sizes in pre-clinical studiesJenna K Felli, Derek J Leishman, Meredith A Steeves
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Journal of Pharmacological and Toxicological Methods|November 16, 2019
Improving prediction of torsadogenic risk in the CiPA in silico model by appropriately accounting for clinical exposureDerek J Leishman
Journal of Clinical Pharmacology|July 17, 2023
The New S7B/E14 Q&A Document Provides Additional Opportunities to Replace the Thorough QT StudyBorje Darpo, Derek J Leishman
Journal of Pharmacological and Toxicological Methods|August 1, 2020
A Bayesian approach to toxicological testingJames C Felli, Derek J Leishman
Journal of Pharmacological and Toxicological Methods|June 28, 2019
Real estate diagrams: A tool to quickly assess the utility of a new predictive technologyJames C Felli, Derek J Leishman
Clinical Pharmacology and Therapeutics|February 22, 2024
The Efficacy, Effectiveness, and Efficiency of Integrated QTc Assessment: Rationalizing Approaches to New Drug ModalitiesMatthew M Abernathy, Derek J Leishman
Clinical Pharmacology and Therapeutics|April 10, 2026
Does Changing the Context of Use Change the Value Proposition of CiPA?Charles T Benson, Derek J Leishman
Clinical and Translational Science|October 15, 2024
A "one-step" approach to heart rate correction and statistical analysis applied to conscious dog QTc studiesDerek D Best, Matthew M Abernathy, Derek J Leishman
Journal of Pharmacological and Toxicological Methods|April 25, 2025
The statistical and pharmacological sensitivity of nonclinical QTc analysis comparing jacketed telemetry and multilead snapshot recording in the same dogsMatthew M Abernathy, Derek D Best, Derek J Leishman
Journal of Pharmacological and Toxicological Methods|August 10, 2020
Revisiting the hERG safety margin after 20 years of routine hERG screeningDerek J Leishman, Matthew M Abernathy, Evan B Wang
Regulatory Toxicology and Pharmacology : RTP|March 31, 2025
Prevalence and sample sizes in pre-clinical studiesJenna K Felli, Derek J Leishman, Meredith A Steeves
Pageof 5